Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2

Low-volume antibody assays can be used to track SARS-CoV-2 infection rates in settings where active testing for virus is limited and remote sampling is optimal. We developed 12 ELISAs detecting total or antibody isotypes to SARS-CoV-2 nucleocapsid, spike protein or its receptor binding domain (RBD),...

Descripción completa

Detalles Bibliográficos
Autores principales: Halliday, Alice, Long, Anna E., Baum, Holly E., Thomas, Amy C., Shelley, Kathryn L., Oliver, Elizabeth, Gupta, Kapil, Francis, Ore, Williamson, Maia Kavanagh, Di Bartolo, Natalie, Randell, Matthew J., Ben-Khoud, Yassin, Kelland, Ilana, Mortimer, Georgina, Ball, Olivia, Plumptre, Charlie, Chandler, Kyla, Obst, Ulrike, Secchi, Massimiliano, Piemonti, Lorenzo, Lampasona, Vito, Smith, Joyce, Gregorova, Michaela, Knezevic, Lea, Metz, Jane, Barr, Rachael, Morales-Aza, Begonia, Oliver, Jennifer, Collingwood, Lucy, Hitchings, Benjamin, Ring, Susan, Wooldridge, Linda, Rivino, Laura, Timpson, Nicholas, McKernon, Jorgen, Muir, Peter, Hamilton, Fergus, Arnold, David, Woolfson, Derek N., Goenka, Anu, Davidson, Andrew D., Toye, Ashley M., Berger, Imre, Bailey, Mick, Gillespie, Kathleen M., Williams, Alistair J. K., Finn, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682908/
https://www.ncbi.nlm.nih.gov/pubmed/36439154
http://dx.doi.org/10.3389/fimmu.2022.968317

Ejemplares similares

Ejemplares similares